Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study

Zhang, J; Hao, YQ; Ou, WL; Ming, F; Liang, G; Qian, Y; Cai, Q; Dong, S; Hu, S; Wang, WD; Wei, SZ

Wang, WD (corresponding author), Sun Yat Sen Univ, Dept Hematol Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China.; Wei, SZ (corresponding author), Huazhong Univ Sci & Technol, Dept Gastrointestinal Surg, Tongji Med Coll, Hubei Canc Hosp, 116 Zhuodaoquan South Rd, Wuhan 430079, Hubei, Peoples R China.; Wei, SZ (corresponding author), Huazhong Univ Sci & Technol, Colorectal Canc Ctr Hubei Prov, Tongji Med Coll, Hubei Canc Hosp, 116 Zhuodaoquan South Rd, Wuhan 430079, Hubei, Peoples R China.

JOURNAL OF TRANSLATIONAL MEDICINE, 2020; 18 (1):

Abstract

Background Interleukin-6 (IL-6) was proposed to be associated with the severity of coronavirus disease 2019 (COVID-19). The present study aimed to exp......

Full Text Link